Moberg Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	212.43	230.95	293.29	60.56	125.55	102.66
Cash & Short-Term Investments	212.43	230.95	293.29	60.56	125.55	102.66
Cash Growth	-16.61%	-21.25%	384.33%	-51.77%	22.30%	432.28%
Accounts Receivable	10.19	2.33	0.17	-	0.38	0.47
Other Receivables	-	0.37	0.64	0.79	1.06	0.66
Receivables	10.19	2.7	0.8	0.79	1.44	1.14
Inventory	3.79	3.58	4.3	7.12	-	-
Prepaid Expenses	-	0.62	1.58	0.9	0.72	0.75
Other Current Assets	-	0.06	0.14	0.14	0.06	0.12
Total Current Assets	226.41	237.91	300.11	69.49	127.76	104.66
Property, Plant & Equipment	2.01	2.81	4.42	4.94	5.98	4.52
Other Intangible Assets	359.88	-	-	-	-	-
Long-Term Deferred Tax Assets	93.09	92.58	95.78	28.08	22.58	14.67
Long-Term Deferred Charges	-	348.96	305.77	532.22	408.1	327.04
Total Assets	681.39	682.26	706.09	634.73	564.42	450.89
Accounts Payable	-	2.93	4.16	6.77	17.11	5.31
Accrued Expenses	-	11.19	10.67	12.5	7.56	7.45
Current Portion of Leases	1.72	1.68	1.6	1.27	2.12	2.7
Other Current Liabilities	16.76	0.38	0.29	-	-	0.09
Total Current Liabilities	18.48	16.17	16.72	20.54	26.79	15.54
Long-Term Leases	-	0.87	2.55	3.47	3.99	1.24
Other Long-Term Liabilities	-	-	-	-	0.07	0.07
Total Liabilities	18.48	17.04	19.27	24.01	30.84	16.84
Common Stock	662.92	47	46.69	27.96	9.83	4.41
Additional Paid-In Capital	-	1,239	1,234	921.3	841.2	731.38
Retained Earnings	-	-620.88	-593.64	-338.53	-317.44	-301.73
Total Common Equity	662.92	665.22	686.82	610.73	533.58	434.05
Shareholders' Equity	662.92	665.22	686.82	610.73	533.58	434.05
Total Liabilities & Equity	681.39	682.26	706.09	634.73	564.42	450.89
Total Debt	1.72	2.55	4.14	4.74	6.11	3.93
Net Cash (Debt)	210.71	228.4	289.15	55.82	119.45	98.72
Net Cash Growth	-16.18%	-21.01%	418.02%	-53.27%	20.99%	730.24%
Net Cash Per Share	4.53	4.88	7.64	3.52	15.74	22.94
Filing Date Shares Outstanding	46.87	47	46.69	27.96	9.83	4.4
Total Common Shares Outstanding	46.87	47	46.69	27.96	9.83	4.4
Working Capital	207.93	221.74	283.39	48.95	100.97	89.12
Book Value Per Share	14.14	14.15	14.71	21.84	54.30	98.54
Tangible Book Value	303.04	665.22	686.82	610.73	533.58	434.05
Tangible Book Value Per Share	6.47	14.15	14.71	21.84	54.30	98.54